Lee Seng Lau conducts translational cancer immunology research in the Dimitroff Lab, with a focus on CAR-T cell engineering and glyco-immunology. Her work examines how galectins and glycosylation pathways regulate T-cell function, persistence, and therapeutic efficacy.
Areas of Expertise
- Cancer immunology
- CAR-T cell Glyco-immunology
- Galectin–glycan interactions
- Tumor-mediated immunosuppression
Research Interests
- Translational cancer immunology and immunotherapy
- Cellular therapies, including CAR-T cell development and optimization
- Immune regulation within the tumor microenvironment
- Glycosylation-dependent mechanisms of immune modulation
- Galectin–glycan interactions in cancer and immune dysfunction
- Molecular and metabolic pathways influencing T-cell persistence and function
- Integration of preclinical and clinical data to improve immunotherapy outcomes
See research publications and more on FIU Discovery.
Honors & Awards
- Outstanding Graduate Student, Florida International University, Presidential office ,2025
- Biomedical Science Graduate Dean Scholarship, Florida International University, 2024
- Johnson & Johnson Scholars of Oncology Diversity Engagement Program, 2024
- Ralph J. Bernacki Translational Glycobiology Research Scholar Award, Florida International University, 2022
- McKnight Doctoral Fellowship, Florida Educational Fund, 2022
Committees & Professional Organizations
- American Association for Cancer Research
- American Association for the Advancement of Science
Education
- Ph.D., Biomedical Science, Florida International University, Miami, FL 2025
- BS, Biological Sciences, Florida International University, Miami, FL 2013